Measles Rubella Cipla
Active ingredient not listed in the SAHPRA register
Cipla Medpro (Pty) Ltd
Registration
- Applicant
- Cipla Medpro (Pty) Ltd
- Certificate holder
- Cipla Medpro (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Measles rubella cipla EACH 0,5 ml DOSE CONTAINS MEASLES VIRUS (EDMONSTON ZAGREB STRAIN) NLT 1000,0 CCID50 RUBELLA VIRUS (WISTAR RA27/3) NLT 1 000,0 CCID50 | NLT 1000,0 CCID50Powder and solvent for solution for subcutaneous injection | 55042655/30.2/0426Approved 23 May 2023 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
The SAHPRA register lists no active ingredient for this product, so there is no compound to show.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.